Sarah Boyce
Chief Executive Officer at AVIDITY BIOSCIENCES, INC.
Net worth: 6 M $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Matthew Foehr | M | 51 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 13 years |
Charles Berkman | M | 55 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 23 years |
Troy Wilson | M | 55 | 12 years | |
Jennifer Cochran | M | 52 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
John Higgins | M | 54 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Todd Brady | M | 45 | 8 years | |
Carolyn Bertozzi | M | 57 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Carmine Stengone | M | 48 | 6 years | |
Joshua Tamaroff | M | 38 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
John W. Wallen | M | 66 | 12 years | |
Arthur Levin | M | 70 | 11 years | |
Eric B. Mosbrooker | M | 46 | 3 years | |
Kathleen Gallagher | F | - | 3 years | |
Vasant Narasimhan | M | 48 | 19 years | |
Eric Vajda | M | - | 21 years | |
Todd Pettingill | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
Tamar Thompson | F | 50 | 3 years | |
Jason Haas | M | 56 | 2 years | |
Marie-Cecile van de Lavoir | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
Noreen Henig | M | 59 | 5 years | |
Octavio Espinoza | M | 53 | 2 years | |
Lori Lyons-Williams | F | 46 | 4 years | |
Samir Shah | M | 63 | 20 years | |
Simona Skerjanec | F | 59 | - | |
Michael MacLean | M | 58 | 4 years | |
Carsten Boess | M | 57 | 4 years | |
Edward Kaye | M | 75 | 5 years | |
Jean Kim | F | 50 | 3 years | |
Steven Love | M | 55 | 1 years | |
Kurt Gustafson | M | 55 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Andrew Reardon | M | 49 | 2 years | |
Daniel Lorrain | M | 55 | 7 years | |
Evert Schimmelpennink | M | 52 | 2 years | |
W. Flanagan | M | 62 | 3 years | |
Steven G. Hughes | M | 57 | 2 years | |
Harry Werner Kirsch | M | 59 | 21 years | |
Benjamin Silbert | M | 54 | - | |
Teresa McCarthy | F | 60 | 4 years | |
Cia McCaffrey | F | - | - | |
Linda Armstrong | M | 61 | 17 years | |
Donna Ventura | F | - | 2 years | |
Christoper Silvia | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Howard Solomon | M | 96 | 49 years | |
Joseph Jimenez | M | 64 | 11 years | |
Andreas Rummelt | M | 67 | 15 years | |
Ronen Tamir | M | 57 | - | |
Siddhartha Kadia | M | 54 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
Gregory Lucier | M | 59 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
Paula Soteropoulos | F | 56 | 4 years | |
Wendelin Wiedeking | M | 72 | 11 years | |
Robert Dolski | M | 54 | 1 years | |
Kurt R. Wood | M | 49 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | 2 years |
Ulrich Lehner | M | 78 | 13 years | |
Rod Wong | M | 47 | 2 years | |
Thomas Wellauer | M | 69 | - | |
Ambrose Bailey | M | 60 | 1 years | |
Richard A. Moscicki | M | 72 | - | |
Michael Martin | M | 50 | 5 years | |
Gerald Lieberman | M | 77 | 3 years | |
Juan Andres | M | 59 | 12 years | |
Dirk van de Put | M | 63 | 1 years | |
Peter Maag | M | 57 | 5 years | |
Jessica Hopfield | M | 59 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
Eric Hobbs | M | 47 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | 9 years |
Ming C. Wu | M | 63 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | 9 years |
Damien McDevitt | M | 57 | 3 years | |
Joshua Patterson | M | 48 | 12 years | |
Andreas von Planta | M | 69 | - | |
Ann Margaret Veneman | F | 75 | - | |
Jürgen Brokatzky-Geiger | M | 72 | 14 years | |
Michael Marks | M | 73 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | 10 years |
Vincent Intrieri | M | 67 | 1 years | |
Solomon David | M | 57 | 12 years | |
John Chiminski | M | 60 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
Mun Tak Yang | F | 70 | - | |
Ann Marie Fudge | F | 72 | - | |
William Brody | M | 80 | - | |
John Kelly | M | 57 | 1 years | |
Betsey Nelson | F | 63 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
Gary Sutton | M | - | 13 years | |
Hans Jörg Reinhardt | M | 68 | 28 years | |
Pierre Legault | M | 63 | 2 years | |
Srikant T. Madhav Datar | M | 70 | 18 years | |
Peter Hawryluk | M | 55 | 7 years | |
Gina Massa Mias | F | - | - | |
Brian Hubbard | M | - | 6 years | |
Marshall E. Reese | M | 78 | 5 years | |
Frank Palantoni | M | 66 | 6 years | |
Paolo Baroldi | M | 73 | 4 years | |
Kevin Smith | M | - | 1 years | |
Ian Garland | M | 59 | - | |
Mihael Polymeropoulos | M | 64 | 5 years | |
Fredrik Ollila | M | - | - | |
Alexandre Grassin | M | 46 | 3 years | |
William George | M | 81 | 10 years | |
Vincent Ippolito | M | 65 | 17 years | |
Beth Calitri | F | - | 8 years | |
Hans-Martin Blickensdoerfer | M | 59 | 2 years | |
Paul Herrling | M | 78 | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 64 | 64.65% |
Switzerland | 36 | 36.36% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sarah Boyce
- Personal Network